Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in Sao Paulo, Brazil: need for continuous surveillance and implementation of active strategies

Imagem de Miniatura
Arquivos
art_RANDI_Low_tetanusdiphtheriaacellular_pertussis_Tdap_vaccine_coverage_among_healthcare_2019.PDF (606.26 KB)
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER BRAZIL
Autores
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.23, n.4, p.231-236, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Vaccination with tetanus-diphtheria-acellular pertussis (Tdap) has been recommended for healthcare workers (HCWs) by Brazilian Ministry of Health since November 2014. Objective: To describe the strategies implemented to improve Tdap uptake, cumulative vaccine coverage after each intervention, variables associated to Tdap vaccination, and reasons for non-vaccination among HCWs of the main building of a quaternary hospital attached to the Sao Paulo University Medical School. Methods: A list of HCWs eligible for pertussis vaccination was generated. From April to December 2015, the following interventions were implemented: note on intern journal reminding the importance of pertussis vaccination; email to the head nurses strengthening vaccine recommendations; lectures on pertussis and Tdap for physicians of Obstetrics and Neonatology Clinics; on-site vaccination by mobile teams at the Obstetrics, Neonatology, and Anesthesiology Clinics. Vaccine coverage was accessed at the end of each month. Multivariate Poisson regression model with a robust error variance was used to evaluate variables associated with Tdap vaccination. Reasons for non-vaccination were evaluated from January to May 2017 through phone calls for HCWs who had not received Tdap. Results: The study included 456 HCWs. After the interventions, Tdap coverage raised from 2.8% to 41.2%. In the multivariate analysis, occupation (physician), working place (obstetrics or anesthesiology) and influenza vaccination in 2015 were independently associated to Tdap vaccination. The main reason for non-vaccination was unawareness of Tdap recommendations. Conclusions: Tdap uptake among HCWs was low in our hospital. Providing vaccination at convenient places/times for HCW seems to be the most efficient strategy to increase vaccine uptake. (C) 2019 Sociedade Brasileira de Infectologia.
Palavras-chave
Pertussis vaccine, Diphtheria tetanus-acellular, pertussis vaccines, Bordetella pertussis, Whopping cough, Health personnel
URI
https://observatorio.fm.usp.br/handle/OPI/34018
Referências
  1. Calderon TA, 2015, J PEDIAT INF DIS SOC, V4, P252, DOI 10.1093/jpids/piu056
  2. de Celles MD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2309
  3. Esolen LM, 2013, AM J INFECT CONTROL, V41, P740, DOI 10.1016/j.ajic.2012.10.012
  4. Gabutti G, 2015, HUM VACC IMMUNOTHER, V11, P108, DOI 10.4161/hv.34364
  5. Guimaraes LM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1222-3
  6. Haviari S, 2015, HUM VACC IMMUNOTHER, V11, P2522, DOI 10.1080/21645515.2015.1082014
  7. Jiang CH, 2018, VACCINE, V36, P214, DOI 10.1016/j.vaccine.2017.11.071
  8. Kassianos George, 2015, Drugs Context, V4, P212268, DOI 10.7573/dic.212268
  9. Leibu R, 2015, J OCCUP ENVIRON MED, V57, P58, DOI 10.1097/JOM.0000000000000294
  10. Lopes MH, 2008, INFECT CONT HOSP EP, V29, P285, DOI 10.1086/528700
  11. Loulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039
  12. Lu PJ, 2014, VACCINE, V32, P572, DOI 10.1016/j.vaccine.2013.11.077
  13. Maltezou HC, 2014, VACCINE, V32, P4876, DOI 10.1016/j.vaccine.2013.10.046
  14. Miller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058
  15. Ministerio da Saude (Brasil). Secretaria de Vigilancia em Saude, 2014, SET INF TECN IMPL VA, P13
  16. Paranthaman K, 2016, PUBLIC HEALTH, V137, P196, DOI 10.1016/j.puhe.2016.02.033
  17. Pulcini C, 2013, VACCINE, V31, P3943, DOI 10.1016/j.vaccine.2013.06.039
  18. Randi BA, 2019, VACCINE, P18
  19. Sao Paulo (Estado). Secretaria do Estado de Saude. Centro deVigilancia Epidemiologica Prof. Alexandre Vranjac, 2014, CTR VIG EP PROF AL V, P8
  20. Seale H, 2009, VACCINE, V27, P3022, DOI 10.1016/j.vaccine.2009.03.038
  21. Walther K, 2015, VACCINE, V33, P2009, DOI 10.1016/j.vaccine.2015.03.013
  22. Williams WW, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6611a1
  23. Williams WW, 2015, MMWR-MORBID MORTAL W, V64, P95

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - ODS/03